CardioPROTECTion With Dapagliflozin in Breast Cancer Patients Treated With AnthrAcycline - PROTECTAA TRIAL
Conditions: Breast Cancer; Heart Failure Interventions: Drug: Dapagliflozin; Drug: Placebo Sponsors: 4th Military Clinical Hospital with Polyclinic, Poland Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Cardiology | Dapagliflozin | Forxiga | Heart | Heart Failure | Hospitals | Poland Health | Research